CoChat

Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?

Speeckaert, M., Van Biesen, W., Delanghe, J., Slingerland, R., Wiecek, A., Heaf, J., Drechsler, C., Lacatus, R., Vanholder, R., Nistor, I., for the European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD, Bilo, H., Bolignano, D., Couchoud, C., Covic, A., Coentrao, L., Sutter, J. D., Drechsler, C., Gnudi, L., Goldsmith, D., Heaf, J., Heimburger, O., Jager, K., Nacak, H., Nistor, I., Soler, M., Tomson, C., Vanhuffel, L., Biesen, W. V., Laecke, S. V., Weekers, L., Wiecek, A. · 2014 · Nephrology Dialysis Transplantation
Cited by 115

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Although measurement of haemoglobin A1c has become the cornerstone for diagnosing diabetes mellitus in routine clinical practice, the role of this biomarker in reflecting long-term glycaemic control in patients with chronic kidney disease has been questioned. METHODS: Consensus review paper based on narrative literature review. RESULTS: As a different association between glycaemic control and morbidity/mortality might be observed in patients with and without renal insufficiency, the European Renal Best Practice, the official guideline body of the European Renal Association-European Dialysis and Transplant Association, presents the current knowledge and evidence of the use of alternative glycaemic markers (glycated albumin, fructosamine, 1,5-anhydroglucitol and continuous glucose monitoring). CONCLUSION: Although reference values of HbA1C might be different in patients with chronic kidney disease, it still remains the cornerstone as follow-up of longer term glycaemic control, as most clinical trials have used it as reference.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfu006

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 115

Metadata

Authors
Speeckaert, M., Van Biesen, W., Delanghe, J., Slingerland, R., Wiecek, A., Heaf, J., Drechsler, C., Lacatus, R., Vanholder, R., Nistor, I., for the European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD, Bilo, H., Bolignano, D., Couchoud, C., Covic, A., Coentrao, L., Sutter, J. D., Drechsler, C., Gnudi, L., Goldsmith, D., Heaf, J., Heimburger, O., Jager, K., Nacak, H., Nistor, I., Soler, M., Tomson, C., Vanhuffel, L., Biesen, W. V., Laecke, S. V., Weekers, L., & Wiecek, A.
Venue
Nephrology Dialysis Transplantation
Published
2014-01-26
Volume
29
Issue
12
Pages
2167-2177
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2138858019
Cited by
115
References
18
FWCI
8.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? https://app.cochat.ai/papers/10.1093/ndt/gfu006
The paper
Speeckaert, M., Van Biesen, W., Delanghe, J., Slingerland, R., Wiecek, A., Heaf, J., Drechsler, C., Lacatus, R., Vanholder, R., Nistor, I., for the European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD, Bilo, H., Bolignano, D., Couchoud, C., Covic, A., Coentrao, L., Sutter, J. D., Drechsler, C., Gnudi, L., . . . Wiecek, A. (2014). Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfu006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.